Aprepitant for preventing chemotherapy-induced nausea and vomiting (CINV) in children

被引：0
|
作者：
Kang, Hyoung Jin
Loftus, Susan
Taylor, Arlene
DiCristina, Cara
Zwaan, Christian M.
Green, Stuart
机构：
[1] Seoul Natl Univ, Childrens Hosp, Dept Pediat Hematol & Oncol, Seoul, South Korea
[2] Merck, Harleysville, PA USA
[3] Merck Res Labs, N Wales, PA USA
[4] Merck & Co Inc, Whitehouse Stn, NJ USA
[5] Erasmus MC Sophia Childrens Hosp, Rotterdam, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20671
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Progress in preventing chemotherapy-induced nausea and vomiting
    Markman, M
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2002, 69 (08) : 609 - +
  • [22] Aprepitant in antiemetic combinations to prevent chemotherapy-induced nausea and vomiting
    Olver, IN
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2004, 58 (02) : 201 - 206
  • [23] Safety evaluation of aprepitant for the prevention of chemotherapy-induced nausea and vomiting
    Ruhlmann, Christina H.
    Herrstedt, Jorn
    EXPERT OPINION ON DRUG SAFETY, 2011, 10 (03) : 449 - 462
  • [24] Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Adolescents: Response
    Gore, Lia
    Chawla, Sant
    Petrelli, Antonio Sergio
    Hemenway, Molly
    Schissel, Debra
    Chua, Vickey
    Carides, Alexandra D.
    Taylor, Arlene
    DeVandry, Suzanne
    Valentine, Jack
    Evans, Judith K.
    Oxenius, Bettina
    PEDIATRIC BLOOD & CANCER, 2009, 53 (07) : 1358 - 1358
  • [25] Efficacy of aprepitant for CHOP chemotherapy-induced nausea, vomiting, and anorexia
    Morita, Mihoko
    Kishi, Shinji
    Ookura, Miyuki
    Matsuda, Yasufumi
    Tai, Katsunori
    Yamauchi, Takahiro
    Ueda, Takanori
    CURRENT PROBLEMS IN CANCER, 2017, 41 (06) : 419 - 425
  • [26] Duration of Chemotherapy-Induced Nausea and Vomiting (CINV) as a Predictor of Recurrent CINV in Later Cycles
    Navari, Rudolph
    Binder, Gary
    Molasiotis, Alex
    Herrstedt, Jorn
    Roeland, Eric J.
    Ruddy, Kathryn J.
    LeBlanc, Thomas W.
    Kloth, Dwight D.
    Klute, Kelsey A.
    Papademetriou, Eros
    Schmerold, Luke
    Schwartzberg, Lee
    ONCOLOGIST, 2022, : 208 - 213
  • [27] Duration of chemotherapy-induced nausea and vomiting (CINV) as a predictor of later-cycle CINV
    Navari, Rudolph M.
    Binder, Gary
    Roeland, Eric J.
    Molassiotis, Alexander
    Ruddy, Kathryn J.
    LeBlanc, Thomas W.
    Kloth, Dwight D.
    Sebastiani, Silvia
    Turini, Marco
    Schmerold, Luke M.
    Liu, Xing
    Schwartzberg, Lee
    CANCER RESEARCH, 2021, 81 (04)
  • [28] REDUCTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) THROUGH TREATMENT WITH CLONAZEPAM
    Koga, Minako
    Nakadozono, Momoe
    Nukariya, Kazutaka
    Nogi, Hiroko
    Kobayashi, Tadashi
    Ochiai, Yusuke
    Nakayama, Kazuhiko
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3354 - 3354
  • [29] APREPITANT REDUCES INCIDENCE OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) AT LOW, MEDIUM AND HIGH CISPLATIN-DOSE STRATA
    Schmoll, H.
    Street, J. C.
    Carides, A. D.
    ANNALS OF ONCOLOGY, 2008, 19 : 283 - 283
  • [30] Challenges in chemotherapy-induced nausea and vomiting (CINV) management: A systematic review
    Badarudin, Nurul Suhaida
    Shah, Noraida Mohamed
    Ismail, Fuad
    Islahudin, Farida
    Tahir, Nurul Ain Mohd
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2024, 23 (03) : 653 - 668
12345